Equities

Electromed Inc

Electromed Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)29.13
  • Today's Change1.06 / 3.76%
  • Shares traded14.01k
  • 1 Year change+182.51%
  • Beta0.2378
Data delayed at least 15 minutes, as of Nov 22 2024 15:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

  • Revenue in USD (TTM)57.06m
  • Net income in USD6.47m
  • Incorporated1992
  • Employees174.00
  • Location
    Electromed Inc500 6th Ave NWNEW PRAGUE 56071United StatesUSA
  • Phone+1 (952) 758-9299
  • Websitehttps://smartvest.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Accuray Inc444.20m-20.08m190.07m987.00--4.20--0.4279-0.2032-0.20324.480.45030.93532.015.25450,054.70-4.23-1.37-7.35-2.3331.0936.43-4.52-1.550.8655-0.09360.7901---0.23551.29-67.51---3.54--
Sight Sciences Inc79.54m-50.35m190.84m214.00--2.00--2.40-1.01-1.011.601.880.49681.555.33371,696.30-31.45-38.78-34.47-42.2085.1180.74-63.30-105.149.74-222.930.2645--13.6360.8435.59--6.77--
Senseonics Holdings Inc22.21m-80.33m191.24m132.00------8.61-0.1302-0.13020.0360.03750.17743.795.94168,219.70-64.16-73.65-81.31-106.97-10.49-40.41-361.77-649.862.38-27.980.7244--36.623.43-142.49---18.76--
InfuSystem Holdings Inc132.78m1.48m196.48m499.00137.113.5314.311.480.06740.06746.152.611.2810.286.29266,100.201.434.601.685.6950.5156.431.124.071.592.880.33510.0014.4413.384,744.44--6.01--
Orchestra Biomed Holdings Inc2.65m-57.69m205.77m56.00--4.47--77.74-1.60-1.600.07341.220.02761.0426.3447,267.86-60.19---74.93--92.71---2,179.34--4.21--0.00---21.88---37.91------
Inogen Inc331.52m-52.69m218.45m834.00--1.18--0.6589-2.25-2.2514.097.781.027.818.03397,506.00-16.21-8.23-20.38-9.5344.2244.54-15.89-10.312.34--0.00---16.32-2.49-22.30--26.34--
Utah Medical Products, Inc.44.08m15.26m224.52m169.0015.101.7912.235.094.274.2712.3636.090.33781.9312.23260,816.6011.6912.6912.0513.1958.8061.5734.6230.5126.94--0.0037.05-3.933.640.98341.659.711.86
Electromed Inc57.06m6.47m235.92m174.0038.695.7232.254.130.72560.72566.404.911.233.372.42327,931.0013.918.6416.2210.0976.6276.2611.348.065.06--0.000.0013.8311.8262.6721.06-22.23--
Trubridge Inc337.67m-58.25m238.95m3.22k--1.38--0.7076-4.09-4.0923.6711.570.8126183.565.84104,900.30-14.401.25-16.501.4149.3150.40-17.721.561.780.80550.505245.063.913.89-387.73--88.71--
LifeMD Inc193.06m-25.61m245.06m207.00------1.27-0.6409-0.64094.85-0.18473.416.2136.89932,652.80-39.18-153.05-240.82-526.9189.6483.66-11.49-45.440.7805-8.831.49--28.1578.9051.27--143.64--
Atlantic International Corp313.06m-68.07m253.24m7.00--14.11--0.8089-5.55-5.5512.450.3584.44--10.4844,723,330.00-96.45-71.97-233.48-106.0910.8161.01-21.74-1,471.82---1.640.8328---100.00---37.43------
Pulmonx Corp79.30m-57.11m253.51m279.00--2.70--3.20-1.47-1.472.042.380.451.247.29284,236.60-32.41-26.27-36.42-28.9774.1671.95-72.01-93.766.77--0.2839--27.9827.98-3.26--20.62--
Anika Therapeutics Inc164.17m-97.52m255.27m357.00--1.42--1.55-6.64-6.6411.1412.240.58681.475.21459,854.30-34.86-5.41-38.55-5.8762.7060.70-59.40-12.603.78--0.00--6.679.56-456.34--3.11--
Zynex Inc193.67m4.82m258.27m1.10k54.767.3327.621.330.14810.14815.911.111.402.577.05176,059.103.4814.584.0617.5280.2079.622.4910.443.154.150.6246--16.5442.01-42.910.37412.19--
Neuropace Inc76.45m-28.09m268.63m171.00--27.28--3.51-0.9924-0.99242.700.32990.78171.836.69447,087.70-28.72---33.44--73.83---36.74--4.77-4.060.8578--43.72--30.00------
AngioDynamics, Inc.292.73m-243.03m282.41m748.00--1.45--0.9648-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
Data as of Nov 22 2024. Currency figures normalised to Electromed Inc's reporting currency: US Dollar USD

Institutional shareholders

27.61%Per cent of shares held by top holders
HolderShares% Held
Summers Value Partners LLCas of 18 Sep 2024550.49k6.55%
The Vanguard Group, Inc.as of 30 Sep 2024365.31k4.35%
Punch & Associates Investment Management, Inc.as of 30 Sep 2024360.24k4.29%
Dimensional Fund Advisors LPas of 30 Sep 2024264.17k3.14%
Acadian Asset Management LLCas of 30 Sep 2024214.10k2.55%
GAMCO Asset Management, Inc.as of 30 Sep 2024135.00k1.61%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 2023126.22k1.50%
Renaissance Technologies LLCas of 30 Sep 2024123.40k1.47%
Hunter Associates Investment Management LLCas of 30 Sep 2024102.45k1.22%
Bridgeway Capital Management LLCas of 30 Sep 202479.36k0.94%
More ▼
Data from 30 Aug 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.